Parathyroid Auto-transplantation: Prospective Randomized Trial of the Personalized Site

NCT02906748 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2016-09-20

No results posted yet for this study

Summary

The functional parathyroid auto-transplantation (PA) could release parathyroid hormone (PTH) into the circulatory system of the body through the capillaries. But when parathyroid glands were auto-grafted in the sternocleidomastoid muscle, it would be inconvenient to detect PTH to examine whether the graft functions. So the investigators took the forearm as the aim place for auto-transplantation, either subcutaneous or brachioradialis, with its relatively fixed - antecubital vein blood test which is simple. The survival criteria is assumed as the PTH gradient of 1.5 times or greater through comparing the bilateral PTH value in grafted and not-grafted forearm.

Conditions

  • Parathyroid Autologous Transplantation

Interventions

PROCEDURE

injection with a syringe in new-site for parathyroid autografting

new-site for parathyroid autografting, close to the antecubital vein

PROCEDURE

injection with a syringe in traditional site for parathyroid autografting

traditional-site for parathyroid autografting,not intensively close to the antecubital vein

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Gaosong Wu, PhD · Department of Thyroid and Breast Surgery Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-06-30
Completion
2018-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02906748 on ClinicalTrials.gov